A "rung bell" is common and can do significant acute and long-term harm to a developing brain. Because no guideline or protocol has been adequately studied for application to children and adolescents, take a cautious approach to management of concussion in youth, the author advises.
Dupilumab (Dupixent) becomes first FDA-approved drug for adolescent CRSwNP
September 13th 2024The landmark indication is supported by a couple of pivotal trials assessing dupilumab for patients with chronic rhinosinusitis with nasal polyps, as well as a pediatric severe asthma trial assessing the biologic.